Cross-sectional survey evaluated tobacco use changes in adults during COVID-19, indicating health improvements.
Background: The COVID-19 pandemic significantly influenced tobacco use, presenting both challenges and opportunities for behavioural change. Understanding these shifts is crucial for targeted public health strategies. Objectives: This study aimed to evaluate changes in tobacco use among adults in Chennai during the COVID-19 pandemic, identify high-risk subgroups, and assess associations between smoking behaviour and self-perceived physical and psychological health. Methods: A cross-sectional survey was conducted among 500 adults (18–65 years) using structured questionnaires. Data included demographics, tobacco consumption before and after the pandemic, COVID-19 infection severity, and self-rated health. Statistical tests and logistic regression were applied. Results: Of the 500 participants, 54% reduced smoking, 32% quit, and 12% increased use. Average daily cigarettes decreased from 15.2 to 9.1 (p<0.001). Rural residents reported greater reduction than urban (p<0.05). Quitting/reducing smoking was associated with improved self-rated health and lower odds of hospitalisation (OR=0.42, 95% CI 0.25–0.72) and ICU admission (OR=0.35, 95% CI 0.19–0.65). Conclusion: The pandemic served as a catalyst for smoking reduction and cessation, with disparities observed among men, long-term smokers, and urban residents. Integrating cessation support into digital platforms and mental health services could consolidate public health gains.
No takes yet. Share an insight, caveat, or question.
Das et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: